tm logo
Trademark Search
BIOARCTIC

View On IC.GC.CA

BIOARCTIC
REGISTERED

on 05 Jan 2024

Last Applicant/ Owned by

BIOARCTIC AB

WARFVINGES VÄG 35SE-112 51 Stockholm

SE

Serial Number

2101420 filed on 14th Dec 2020

Registration Number

TMA1216984 registered on 05th Jan 2024

Registration expiry Date

14th Dec 2030

Correspondent Address

190 O'CONNOR STREETSUITE 710OTTAWA

ONTARIO

CA

K2P2R3

BIOARCTIC

Trademark usage description

active chemical ingredients, chemical additives, and chemical preparations for use in the manufacture of pharmaceuticals; biochemical preparations for Read More

Classification Information

Class [001]
Active chemical ingredients, chemical additives, and chemical preparations for use in the manufacture of pharmaceuticals; biochemical preparations for scientific purposes for use in the manufacture of pharmaceuticals; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; diagnostic reagents for medical-scientific research use; in vitro diagnostic reagents for scientific use; reagents for use in the development of antibodies [other than for medical or veterinary purposes]; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products; biochemicals in the form of monoclonal antibodies for research and in vitro scientific use, except for medical or veterinary use; cell culture media and reagents for scientific or research purposes, other than for medical or veterinary use

Classification kind code

11

Class [005]
Medical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; biochemical preparations for medical use for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; diagnostic preparations for in vitro testing for medical use and for medical laboratory use; medical therapeutic agents for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; diagnostic reagents for medical diagnostic use; diagnostic biochemical biomarkers for in vitro testing for medical use; diagnostic biomarker reagents for medical purposes; live organs and tissues for surgical purpose; living cells for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; stem cells for medical purposes; sanitary preparations for medical purposes, namely, hand sanitizers and disinfectants for medical instruments; dietetic substances consisting of vitamins, minerals, amino acids and trace elements, adapted for medical purposes

Classification kind code

11

Class [010]
Medical apparatus and instruments, namely, syringes for medical purposes, syringes for injections, hypodermic syringes; medical image processors; magnetic resonance imaging [MRI] apparatus for medical use; medical devices for the diagnosis and treatment of neurological disorders and central nervous system disorders, namely, Alzheimer's, Huntington's disease, Parkinson's disease, brain injuries, amyotrophic lateral sclerosis (ALS), Down syndrome, Gaucher's disease, multiple system atrophy (MSA), traumatic brain injuries, and seizure disorders; surgical instruments

Classification kind code

11

Class [042]
Scientific and technological services, namely, scientific research and product design and development in the field of neurological disorders and central nervous system disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; medical and scientific services and research in the field of the central nervous system, brain disorders and central nervous system related disorders, diseases and pharmaceuticals; medical and scientific research in the field of neurological and neurodegenerative diseases; conducting clinical trials; providing information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation

Classification kind code

11

Class [044]
Human health care services for treating neurological disorders and central nervous system disorders; medical analysis and treatment services relating to the diagnosis and treatment of neurological disorders and central nervous system disorders; providing medical information in the field of neurological disorders and central nervous system disorders; physical examination; rental of medical machines and apparatus; providing information relating to the rental of medical machines and apparatus; medical diagnostic services; optical imaging for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes

Classification kind code

11

Class [045]
Legal services; licensing of intellectual property

Classification kind code

11

Mark Details

Serial Number

2101420

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 07th Dec 2022		Agent Changed
Submitted for opposition 22
on 08th Aug 2022		Search Recorded
Submitted for opposition 20
on 08th Aug 2022		Examiner's First Report
Submitted for opposition 223
on 08th Aug 2022		Total Provisional Refusal
Submitted for opposition 256
on 22nd Feb 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 22nd Apr 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 21st Apr 2021		Created
Submitted for opposition 31
on 21st Apr 2021		Formalized
Submitted for opposition 30
on 14th Dec 2020		Filed
Submitted for opposition 228
on 14th Dec 2020		International Registration